Cargando…

Defective Severe Acute Respiratory Syndrome Coronavirus 2 Immune Responses in an Immunocompromised Individual With Prolonged Viral Replication

We describe severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)–specific immune responses in a patient with lymphoma and recent programmed death 1 (PD-1) inhibitor therapy with late onset of severe coronavirus disease 2019 disease and prolonged SARS-CoV-2 replication, in comparison to age-m...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gordon, Claire L, Smibert, Olivia C, Holmes, Natasha E, Chua, Kyra Y L, Rose, Morgan, Drewett, George, James, Fiona, Mouhtouris, Effie, Nguyen, Thi H O, Zhang, Wuji, Kedzierski, Lukasz, Rowntree, Louise C, Chua, Brendon Y, Caly, Leon, Catton, Mike G, Druce, Julian, Sait, Michelle, Seemann, Torsten, Sherry, Norelle L, Howden, Benjamin P, Kedzierska, Katherine, Kwong, Jason C, Trubiano, Jason A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Brief Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8419740/ https://www.ncbi.nlm.nih.gov/pubmed/34514016 http://dx.doi.org/10.1093/ofid/ofab359

Ejemplares similares

Immune responses in COVID-19 respiratory tract and blood reveal mechanisms of disease severity
por: Zhang, Wuji, et al.
Publicado: (2021)

The Role of Immunological and Clinical Biomarkers to Predict Clinical COVID-19 Severity and Response to Therapy—A Prospective Longitudinal Study
por: Copaescu, Ana, et al.
Publicado: (2021)

Evolution of the Human Cytokine Response from Acute Illness to Disease Resolution in SARS-Cov-2 Infection—Implications for Therapeutic Monitoring and Therapeutic Targets
por: Drewett, George P., et al.
Publicado: (2021)

The use of procalcitonin as an antimicrobial stewardship tool and a predictor of disease severity in coronavirus disease 2019 (COVID-19)
por: Drewett, George P., et al.
Publicado: (2021)

SARS-CoV-2 infection results in immune responses in the respiratory tract and peripheral blood that suggest mechanisms of disease severity
por: Zhang, Wuji, et al.
Publicado: (2022)

Staff to staff transmission as a driver of healthcare worker infections with COVID-19
por: Gordon, Claire L., et al.
Publicado: (2021)

1578. Back to Bactrim–Utilizing Preferred Prophylaxis Strategies in Immunocompromised Hosts Via a Trimethoprim-Sulfamethoxazole Rechallenge Program
por: Smibert, Olivia, et al.
Publicado: (2018)

Corrigendum: Dose Dependent Antimicrobial Cellular Cytotoxicity—Implications for ex vivo Diagnostics
por: Copaescu, Ana, et al.
Publicado: (2021)

Dose Dependent Antimicrobial Cellular Cytotoxicity—Implications for ex vivo Diagnostics
por: Copaescu, Ana, et al.
Publicado: (2021)

The Safety and Efficacy of an Oral Penicillin Challenge Program in Cancer Patients: A Multicenter Pilot Study
por: Trubiano, Jason A, et al.
Publicado: (2018)

Blister fluid as a cellular input for ex vivo diagnostics in drug-induced severe cutaneous adverse reactions improves sensitivity and explores immunopathogenesis
por: Awad, Andrew, et al.
Publicado: (2021)

Lymphocytic Choriomeningitis Virus Infection, Australia
por: Caly, Leon, et al.
Publicado: (2022)

CD8(+) T cells specific for an immunodominant SARS-CoV-2 nucleocapsid epitope display high naive precursor frequency and TCR promiscuity
por: Nguyen, Thi H.O., et al.
Publicado: (2021)

Tracking the COVID-19 pandemic in Australia using genomics
por: Seemann, Torsten, et al.
Publicado: (2020)

Are NKT cells a useful predictor of COVID-19 severity?
por: Koay, Hui-Fern, et al.
Publicado: (2022)

Clinical evaluation of four commercial immunoassays for the detection of antibodies against established SARS-CoV-2 infection
por: Chua, Kyra Y.L., et al.
Publicado: (2020)

The First Isolation and Whole Genome Sequencing of Murray Valley Encephalitis Virus from Cerebrospinal Fluid of a Patient with Encephalitis
por: Russell, Jessica S., et al.
Publicado: (2018)

Functional analysis of the first complete genome sequence of a multidrug resistant sequence type 2 Staphylococcus epidermidis
por: Lee, Jean Y. H., et al.
Publicado: (2016)

COVID-MATCH65—A prospectively derived clinical decision rule for severe acute respiratory syndrome coronavirus 2
por: Trubiano, Jason A., et al.
Publicado: (2020)

The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro
por: Caly, Leon, et al.
Publicado: (2020)

Use of emerging testing technologies and approaches for SARS-CoV-2: review of literature and global experience in an Australian context
por: Graham, Maryza, et al.
Publicado: (2021)

Integrated immune dynamics define correlates of COVID-19 severity and antibody responses
por: Koutsakos, Marios, et al.
Publicado: (2021)

Phenotypic distribution and tolerability of re-vaccination in individuals with delayed hypersensitivity to COVID-19 vaccines
por: De Luca, Joseph, et al.
Publicado: (2023)

High expression of CD38 and MHC class II on CD8(+) T cells during severe influenza disease reflects bystander activation and trogocytosis
por: Jia, Xiaoxiao, et al.
Publicado: (2021)

Robust correlations across six SARS‐CoV‐2 serology assays detecting distinct antibody features
por: Rowntree, Louise C, et al.
Publicado: (2021)

Breadth of concomitant immune responses prior to patient recovery: a case report of non-severe COVID-19
por: Thevarajan, Irani, et al.
Publicado: (2020)

Prolonged Detection of Japanese Encephalitis Virus in Urine and Whole Blood in a Returned Short-term Traveler
por: Huang, G Khai Lin, et al.
Publicado: (2017)

Immunosuppression for COVID-19: repurposing medicines in a pandemic
por: Shivakumar, Senthuran, et al.
Publicado: (2020)

The Dominant Australian Community-Acquired Methicillin-Resistant Staphylococcus aureus Clone ST93-IV [2B] Is Highly Virulent and Genetically Distinct
por: Chua, Kyra Y. L., et al.
Publicado: (2011)

Adaptive Change Inferred from Genomic Population Analysis of the ST93 Epidemic Clone of Community-Associated Methicillin-Resistant Staphylococcus aureus
por: Stinear, Timothy P., et al.
Publicado: (2014)

Asystolic cardiac arrest following liposomal amphotericin B infusion: anaphylaxis or compliment activation-related pseudoallergy?
por: Drewett, George P., et al.
Publicado: (2021)

The role of IL-6 and other mediators in the cytokine storm associated with SARS-CoV-2 infection
por: Copaescu, Ana, et al.
Publicado: (2020)

COVID-Care – a safe and successful digital self-assessment tool for outpatients with proven and suspected coronavirus-2019
por: Drewett, George P, et al.
Publicado: (2021)

Validation of a single-step, single-tube reverse transcription loop-mediated isothermal amplification assay for rapid detection of SARS-CoV-2 RNA
por: Lee, Jean Y. H., et al.
Publicado: (2020)

Individual and community predictors of urinary ceftriaxone-resistant Escherichia coli isolates, Victoria, Australia
por: Chua, Kyra Y. L., et al.
Publicado: (2019)

Delayed cutaneous hypersensitivities to COVID-19 vaccination: Phenotypic distribution and tolerability of vaccine rechallenge
por: De Luca, Joseph F., et al.
Publicado: (2023)

Multi-site assessment of rapid, point-of-care antigen testing for the diagnosis of SARS-CoV-2 infection in a low-prevalence setting: A validation and implementation study
por: Muhi, Stephen, et al.
Publicado: (2021)

1787. The Safety and Efficacy of an Oral Penicillin Rechallenge Program in Cancer Patients: A Pilot Multicenter Study
por: Smibert, Olivia, et al.
Publicado: (2018)

Use of a penicillin allergy clinical decision rule to enable direct oral penicillin provocation: an international multicentre randomised control trial in an adult population (PALACE): study protocol
por: Copaescu, Ana-Maria, et al.
Publicado: (2022)

Study protocol: Australasian Registry of Severe Cutaneous Adverse Reactions (AUS-SCAR)
por: James, Fiona, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ka0o86k3hvlcairfti6t7f0slb